A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies TM (ALT ® ) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza ®

Miguel A. López‐Toledano, Ahmed Daak, Kevin C. Maki, Colleen Johns, Adrián L. Rabinowicz, Frederick D. Sancilio

Clinical Therapeutics · 2017 · 28 citations · 18 references

Concepts

References

18